cognitive function

Related by string. cognitive functions * Cognitive : mild cognitive impairment . cognitive decline . cognitive functioning . cognitive behavioral therapy . cognitive deficits . cognitive psychology / functions . functioning . functioned . Function . Functions . Functioning : Email Alerts Function . smooth functioning . lung function . kidney function . thyroid function . excretory functions between * *

Related by context. All words. (Click for frequent words.) 80 cognitive functioning 78 cognition 73 cognitive 73 cognitive functions 72 cognitive decline 72 cognitive abilities 68 cognitive impairment 68 endothelial function 67 cardiorespiratory fitness 67 neurocognitive function 66 hippocampal volume 66 lung function 66 insulin sensitivity 66 neurocognitive 65 brain shrinkage 65 glucose tolerance 65 cognitive deficits 65 mild cognitive impairment 65 glucose metabolism 65 kidney function 65 psychosocial functioning 64 daytime alertness 63 lipid profiles 63 depressive symptoms 63 mild cognitive 62 cognitive domains 62 arterial stiffness 62 thyroid function 62 dietary intake 62 mitochondrial function 62 dietary supplementation 62 bone density 61 HRQOL 61 telomere length 61 serum cholesterol 61 uric acid levels 61 cognitive dysfunction 61 adiponectin levels 61 cardiac autonomic 61 urate levels 61 lipid levels 60 adrenal function 60 mental acuity 60 magnesium intake 60 synaptic function 60 MMSE scores 60 glucose homeostasis 60 fasting insulin 60 ADHD symptoms 60 insulin resistance 60 neurocognitive functioning 60 fasting glucose levels 60 cardio respiratory fitness 59 neurodevelopmental outcomes 59 amnestic mild cognitive impairment 59 elevated homocysteine 59 hippocampal function 59 neuropsychological 59 erectile function 59 neurodevelopment 59 donepezil 59 fat oxidation 59 psychomotor 58 muscle protein synthesis 58 growth hormone secretion 58 cognitively normal 58 dietary intakes 58 salivary cortisol 58 impaired cognition 58 neurodevelopmental outcome 58 fasting plasma glucose 58 homocysteine levels 58 colorectal adenomas 58 daytime sleepiness 58 HPA axis 58 neurobehavioral 58 inflammatory markers 58 brain atrophy 58 metabolic syndrome 58 ADAS Cog 58 HbA1c levels 58 renal function 58 subclinical hypothyroidism 58 endothelial dysfunction 58 insulin secretion 57 diastolic function 57 thyroid hormone levels 57 Alzheimer pathology 57 metabolic parameters 57 blood glucose levels 57 neuronal function 57 blood lipids 57 CLA supplementation 57 mental alertness 57 carbohydrate metabolism 57 albuminuria 57 bone mineral 57 calcium supplementation 57 postural stability 57 prefrontal cortical 57 serum calcium 57 vitamin B# supplements 57 serum folate 57 albumin excretion 57 T1DM 57 folate intake 56 antioxidant supplementation 56 plasma lipids 56 Caloric restriction 56 ACh 56 neuropsychological tests 56 locomotor activity 56 improves insulin sensitivity 56 calorie diets 56 symptom severity 56 cortisol levels 56 dietary calcium intake 56 serum lipid levels 56 clinically meaningful improvements 56 lipid parameters 56 metabolic 56 Alzheimer disease 56 atypical neuroleptics 56 cardiometabolic risk 56 acetylcholine neurotransmitter 56 skeletal muscle mass 56 parietal cortices 56 serum sodium 56 systolic blood pressure 56 glycosylated hemoglobin HbA1c 56 cortical thickness 56 metabolic abnormalities 56 prolactin levels 56 nondepressed 56 ovarian hormones 56 carotid IMT 56 plasma folate 56 nutrient intake 56 C reactive protein 56 Parkinson disease PD 56 neuromotor 56 synaptic plasticity 56 hippocampal volumes 56 premorbid 55 poststroke 55 aldosterone 55 physiological arousal 55 glycemia 55 remyelination 55 serum vitamin D 55 white matter hyperintensities 55 normotensive 55 antihypertensive therapy 55 neuropathological 55 premenopause 55 fasting blood glucose 55 neurological 55 calcium homeostasis 55 Concord grape juice 55 cortisol secretion 55 serum glucose 55 psychomotor skills 55 antioxidant intake 55 vegetable intake 55 left ventricular systolic 55 subclinical atherosclerosis 55 dementia 55 calorie restriction 55 triglyceride levels 55 depressive symptomatology 55 Kivipelto 55 metabolic syndrome MetS 55 supplementation 55 ovarian function 55 folic acid supplementation 55 EphB2 levels 55 WOMAC pain 55 psychosocial variables 55 HbA 1c 55 serum BDNF 55 abstinent alcoholics 55 lipid metabolism 55 MetS 55 neuropsychiatric symptoms 55 serum phosphate 55 glycemic control 55 coronary endothelial 55 calcium metabolism 55 serum lipids 54 transaminase levels 54 HRQoL 54 folate supplementation 54 β cell 54 cognitive stimulation 54 pulmonary function 54 plasma glucose 54 neuroimaging studies 54 flow mediated dilation 54 verbal fluency 54 serum uric acid 54 inflammatory biomarkers 54 ventricular enlargement 54 impaired endothelial 54 adiposity 54 visual acuity 54 fasting glucose 54 daytime drowsiness 54 platelet function 54 thyrotropin levels 54 glucocorticoid 54 extrapyramidal symptoms 54 autonomic dysfunction 54 hemoglobin A1c levels 54 carotid atherosclerosis 54 cortical thinning 54 telomere lengths 54 dietary DHA 54 levodopa 54 SGRQ 54 DHA supplementation 54 paricalcitol 54 sleep disturbances 54 neurodegeneration 54 dietary restriction 54 coronary calcification 54 RLS symptoms 54 serum folate concentrations 54 folate deficiency 54 glucose intolerance 54 nondemented 54 somatic symptoms 54 tHcy concentrations 54 perimenopausal women 54 colorectal adenoma 54 Depressive symptoms 54 QoL 54 APOE genotype 54 creatine supplementation 54 cognitive impairments 54 HRQL 54 plasma triglycerides 54 hyperglycaemia 54 QTc interval 54 triacylglycerol concentrations 54 blood glucose concentrations 54 parasympathetic tone 54 dietary glycemic index 54 neurogenesis 54 serotonergic neurons 54 left ventricular diastolic 54 brain plasticity 54 serum parathyroid hormone 54 fatty acid oxidation 54 parkinsonism 54 aerobic fitness 54 inhibitory neurotransmitters 54 hsCRP levels 54 neurocognitive deficits 54 glycemic diet 54 leptin deficient mice 54 attentional 54 serum concentrations 54 physiological 53 amyloid plaque formation 53 fructose intake 53 microalbuminuria 53 index BMI 53 MMSE 53 neurological abnormalities 53 thyroid dysfunction 53 plasma leptin 53 liver histology 53 GH deficiency 53 bone metabolism 53 Endothelial function 53 homeostatic 53 plasma lipid 53 psychophysiological 53 Insulin sensitivity 53 galanin 53 platelet activation 53 neural substrates 53 postmenopausal women 53 neurologic 53 platelet aggregation 53 metabolism 53 intelligence quotient IQ 53 attention-deficit/hyperactivity disorder ADHD 53 homocysteine concentrations 53 rCBF 53 cortical activation 53 hepatic fibrosis 53 dietary interventions 53 calcium intake 53 hydroxyvitamin D levels 53 urinary excretion 53 intima media thickness 53 MMSE score 53 serum retinol 53 serum PTH 53 CHD mortality 53 vascular reactivity 53 visuospatial skills 53 Calorie restriction 53 glycosylated hemoglobin levels 53 sensorimotor 53 brain lesions 53 cognitively 53 pharmacological therapies 53 serum IGF 53 neuro cognitive 53 oxygen uptake 53 serum insulin 53 apnea hypopnea index 53 amyloid pathology 53 valproate 53 serum lipid 53 affective disorders 53 neuroprotective effects 53 aspirin NSAIDs 53 parkinsonian 53 cerebral oxygenation 53 airway reactivity 53 cardiovascular mortality 53 urinary albumin 53 creatinine levels 53 homocysteine 53 neuronal degeneration 53 neurobehavioral functioning 53 hemoglobin A1C 53 polycystic ovary syndrome PCOS 53 visuospatial abilities 53 neuronal plasticity 53 insulin sensitizing drugs 53 follicle stimulating hormone FSH 53 serum phosphate levels 53 DHA fatty acid 53 testosterone supplementation 53 androgen depletion 53 gastrointestinal motility 53 calcium absorption 53 vascular dysfunction 53 KIBRA 53 neurobehavioural 53 glucose lowering 53 micronutrient intake 52 nitric oxide bioavailability 52 aMCI precursor 52 parkinsonian symptoms 52 hormone secretion 52 serum estradiol 52 locomotor training 52 polyphenol content 52 amblyopic 52 Sjögren syndrome 52 medial temporal 52 postmenopause 52 cholinesterase inhibitors 52 chromium picolinate 52 bone resorption 52 glycated hemoglobin levels 52 perimenopause 52 vasomotor symptoms 52 HbA1C 52 Parkinsonian 52 8 OHdG 52 glycogen metabolism 52 L dopa 52 Cognitive 52 plasma homocysteine 52 serum testosterone 52 leptin deficient 52 plasma glucose levels 52 etanercept 52 QT intervals 52 neurodevelopmental 52 Ginkgo biloba 52 LDL cholesterol levels 52 telomerase activity 52 neurohormonal 52 hemoglobin concentration 52 DHEAS 52 aerobic capacity 52 thiazide diuretics 52 Francine Grodstein 52 adiponectin 52 plasma homocysteine levels 52 sweat chloride 52 affective psychoses 52 disease progression 52 HAQ DI 52 thyroid hormone 52 postmenopausal 52 Thyroid hormone 52 dietary antioxidants 52 Cortisol levels 52 caffeine intake 52 BMI z 52 alpha carotene 52 serum homocysteine 52 cardio protective 52 sarcopenia 52 amyloid beta plaque 52 brain neurochemistry 52 impaired glucose tolerance 52 NPH insulin 52 amyloid β 52 aMCI 52 serum creatinine levels 52 antidepressant efficacy 52 facial symmetry 52 neuropsychological functioning 52 DHA supplements 52 aortic stiffness 52 knee OA 52 sodium excretion 52 mild cognitive impairments 52 impaired fasting glucose 52 pre menopausal 52 post menopausal 52 calcium intakes 52 pharmacological interventions 52 knee osteoarthritis 52 nonfasting triglycerides 52 hippocampal 52 neuronal activity 52 femoral neck BMD 52 A1C levels 52 cognitively intact 52 temporal cortex 52 subcortical 52 hypothalamic pituitary adrenal axis 52 nerve degeneration 52 hypoglycemia unawareness 52 hyperinsulinemia 52 N telopeptide 52 blood sugar 52 posttransplant 52 dietary fatty acids 52 elevated creatinine 52 carbohydrate cravings 52 compensatory mechanisms 52 non aspirin NSAIDs 52 dopaminergic therapy 52 fatty acid metabolism 52 leptin concentrations 52 ginkgo extract 52 cerebral infarction 52 hypothalamic 52 physiologic 52 diastolic BP 52 UCP2 52 neurocognition 52 HDL cholesterol 52 cyclic HMB 52 elevated triglyceride levels 52 systolic 52 psychomotor speed 52 skin elasticity 52 amnestic MCI 52 serum calcium levels 52 levodopa therapy 52 activity MAOA 52 impair cognitive 52 Carnethon 52 Mild cognitive impairment 51 flavanol 51 cardiovascular disease 51 euthymic 51 hippocampal neurogenesis 51 blood Phe levels 51 thyroid hormones 51 intact parathyroid hormone 51 electroencephalographic 51 RBP4 levels 51 clinically meaningful 51 neurotransmitter GABA 51 folates 51 Unified Parkinson Disease 51 arterial stiffening 51 exhaled nitric oxide 51 serum markers 51 drank caffeinated 51 baroreflex sensitivity 51 hippocampal neurons 51 vitamin B# deficiency 51 APOE4 51 neurohormone 51 selenium supplementation 51 Cognitive impairment 51 folate metabolism 51 pituitary hormone 51 RBP4 51 CPAP adherence 51 serum potassium 51 comorbid anxiety 51 macrovascular disease 51 Fasudil 51 postmenopausal breast cancer 51 magnetic stimulation 51 venlafaxine XR 51 dietary folate 51 idiopathic Parkinson disease 51 tHcy 51 disease NAFLD 51 prolactin elevation 51 abstract reasoning 51 penile erection 51 MS relapses 51 acetyl L carnitine 51 cholesterol metabolism 51 neurobiological 51 autoregulation 51 Triglyceride levels 51 leptin 51 baroreceptor reflex 51 estrogen metabolism 51 docosahexaenoic acid DHA 51 Alzheimer Disease Assessment 51 neurosensory 51 perceptual abilities 51 stimulant medications 51 arterial thickening 51 locomotor 51 APOE e4 51 flavonoid rich 51 visuospatial processing 51 CETP gene 51 IUGR 51 alcoholic fatty liver 51 vessel dilation 51 APOE gene 51 triglyceride concentrations 51 visuomotor 51 stress hormone cortisol 51 spatial reasoning 51 shorter telomeres 51 L DOPA 51 urinary symptoms 51 cystatin C 51 atherosclerotic disease 51 VO2 peak 51 orbital frontal cortex 51 glucocorticoid hormones 51 prediabetic 51 fat diet 51 NYHA functional class 51 hemoglobin A1c HbA1c 51 folate 51 Daytime sleepiness 51 metabolic disturbances 51 glucose uptake 51 systolic function 51 serum cortisol 51 calcitriol 51 body fatness 51 vitamin B# 51 N acetylaspartate 51 insulin resistance syndrome 51 corrected QT interval 51 Health Assessment Questionnaire 51 elevated triglycerides 51 aminotransferases 51 QTc 51 lipoic acid 51 shorter telomere length 51 metabolic acidosis 51 alanine aminotransferase ALT 51 HbA1C levels 51 urinary oxalate 51 hippocampal dysfunction 51 glomerular filtration 51 Alzheimer disease pathology 51 motor neuron degeneration 51 NAFLD 51 prostate carcinogenesis 51 dietary carbohydrate 51 microvascular complications 51 LVEF 51 hydroxyvitamin D 51 ursodeoxycholic acid 51 systolic BP 51 ADAS cog 51 alexithymia 51 triiodothyronine 51 cortical regions 51 tiotropium 51 Calcium intake 51 LUTS 51 wakefulness 51 hemoglobin concentrations 51 OSAHS 51 carbohydrate restriction 51 atherogenic dyslipidemia 51 lipoprotein 51 Erectile function 51 neutrophil counts 51 radiographic progression 51 metabolic dysfunction 51 polyphenol rich 51 troponin T 51 allostatic load 51 cardiovascular disease hypertension 51 dysbindin gene 51 serum testosterone levels 51 nondiabetics 51 capillary density 51 neuronal dysfunction 51 non affective psychosis 51 p# activation 51 β amyloid 51 sperm motility 51 insulin detemir 51 unmeasured factors 51 lipoprotein levels 51 platelet reactivity 51 APOE ε4 51 QTc intervals 51 amino acid homocysteine 51 proliferative diabetic retinopathy 51 brain scans 51 amygdala reactivity 51 cochlear implantation 51 coronary artery calcium 51 ginkgo 51 Alzheimers disease 50 Ginkgo Biloba 50 intestinal microflora 50 amyloid deposition 50 reproductive hormones 50 term potentiation LTP 50 declarative memory 50 dopamine signaling 50 neural plasticity 50 tau pathology 50 blood lactate 50 postprandial glucose 50 abdominal adiposity 50 Subgroup analysis 50 metabolic abnormality 50 ejection fractions 50 phytoestrogen 50 depressive symptom 50 fatty acid supplementation 50 pressor response 50 placebo 50 dietary patterns 50 ginkgo biloba extract 50 hormones leptin 50 glycosylated hemoglobin 50 vitamin D supplementation 50 hsCRP 50 peak VO2 50 tDCS 50 atherosclerosis 50 magnesium supplementation 50 aripiprazole 50 c reactive protein 50 soy isoflavones 50 synaptic transmission 50 fetuin 50 nondiabetic 50 extracellular dopamine 50 prehypertension 50 intestinal permeability 50 cognitive perceptual 50 thyroxine 50 neuropsychological deficits 50 creatine kinase 50 conduction velocity 50 pubertal 50 dyslipidaemia 50 hormone adiponectin 50 serum clusterin levels 50 oxcarbazepine 50 clomipramine 50 triglycerides 50 testicular function 50 intravenous CK # 50 severe hypoglycaemia 50 preterm infants 50 antihypertensive medications 50 Longitudinal studies 50 coenzyme Q# 50 glycated hemoglobin HbA1c 50 diastolic blood pressure 50 apoE4 50 LDL cholesterol concentrations 50 myelin breakdown 50 intestinal motility 50 comorbid depression 50 mood disorders 50 knee osteoarthritis OA 50 irritability insomnia 50 pressure natriuresis 50 salivary flow 50 fructose intolerant 50 hypoglycemic episodes 50 cataract formation 50 calcium excretion 50 postnatally 50 BH4 50 tissue oxygenation 50 orthostatic 50 hepatic steatosis 50 allopregnanolone 50 dopamine neuron 50 nighttime awakenings 50 dysbindin 50 prolactin 50 abnormal lipids 50 dyskinesias 50 SIRT1 protein 50 probiotic supplementation 50 lowers blood glucose 50 hippocampi 50 insulin glargine 50 apneic episodes 50 mIU L 50 lymphocyte counts 50 ADCS ADL 50 artery stenosis 50 dopamine D2 receptors 50 liver enzymes 50 Sirt3 50 retinal nerve 50 brain circuitry 50 Sacktor 50 severe hypoglycemia 50 collagen synthesis 50 docosahexaenoic acid 50 circadian clock genes 50 neuronal signaling 50 density lipoprotein HDL cholesterol 50 D2 receptor 50 perceptual reasoning 50 prefrontal regions 50 systolic hypertension 50 cortisol concentrations 50 Leitzmann 50 fluoxetine Prozac 50 HbA 1c levels 50 serotonergic 50 endothelium dependent 50 beta endorphin 50 overactive bladder symptoms 50 hypogonadal men 50 hippocampal atrophy 50 HOMA IR 50 hepatic enzymes 50 protein excretion 50 juvenile idiopathic arthritis 50 serum selenium 50 reflux symptoms 50 myelination 50 bulimia nervosa 50 Parkinson disease 50 EDSS scores 50 anticholinergic drugs 50 Singh Manoux 50 HDL C 50 fructose diet 50 ApoE4 50 ventricular function 50 Visual acuity 50 loop diuretics 50 impaired glucose metabolism 50 pramipexole 50 longitudinal studies 50 anterior cingulate 50 hypertensives 50 serotonin neurotransmitter 50 algal DHA 50 neurotransmitter serotonin 50 GI motility 50 subclinical hyperthyroidism 50 overt nephropathy 50 dysregulation 50 Apgar scores 50 pathophysiological mechanisms 50 tibolone 50 vascular dementia 50 serum sodium levels 50 mucosal healing 50 antioxidant enzyme 50 FASPS 50 hemodynamics 50 hyperoxia 50 impulsivity 50 EEGs 50 major depressive disorder 50 Alzheimer disease AD 50 State Examination MMSE 50 cardioprotective effects 50 daytime somnolence 50 A1c levels 50 activate AMPK 50 apolipoprotein B 50 #OHD levels 50 mitochondrial respiration 50 safinamide 50 citalopram 50 PANSS scores 50 baseline HbA1c 50 potassium sparing diuretics 50 asymptomatic carotid stenosis 50 antidiabetic therapy 50 adiponectin concentrations 50 vitamin B6 50 transferrin saturation 50 brain 50 tic severity 50 IBS symptoms 50 NMDA receptors 50 fractional anisotropy 50 Vitamin D supplementation 50 striatal dopamine 49 folic acid intake 49 nocturnal hemodialysis 49 cardiovascular 49 postoperative delirium 49 nerve conduction velocity 49 N acetylcysteine 49 hypersomnia 49 serum PSA 49 posttreatment 49 oxidative stress 49 SIRT1 49 AST ALT 49 normal physiologic 49 ginkgo biloba 49 NIHSS 49 metabolite concentrations 49 #mg/day [002] 49 hypertension diabetes mellitus 49 Mild Cognitive Impairment 49 serum bicarbonate 49 euthymic patients 49 plasma cortisol 49 highest tertile 49 Vitamin D supplements 49 HIV HCV coinfected 49 auditory processing 49 GH secretion 49 Scale cognitive subscale 49 myo inositol 49 bezafibrate 49 corticosterone levels 49 alanine aminotransferase 49 iron supplementation 49 planum temporale 49 postural sway 49 VMAT2 49 hormone aldosterone 49 platelet inhibition 49 postmenopausal estrogen 49 pyridostigmine 49 GABA gamma aminobutyric acid 49 #.#mmol L [002] 49 neural degeneration 49 serum urate 49 fasting triglyceride levels 49 hippocampus 49 interpersonal psychotherapy 49 neuroleptics 49 Practicing yoga 49 receptor subtypes 49 baroreflex 49 neurotransmitter acetylcholine 49 glargine 49 T2DM 49 NIHSS score 49 haemorrhagic stroke 49 BCAAs 49 iron deficient 49 angiotensin receptor blockers ARBs 49 postprandial insulin 49 pioglitazone 49 methylation patterns 49 nocturnal hypoglycaemia 49 suppresses appetite 49 hyperphenylalaninemia HPA due 49 experimentally induced 49 spontaneous erections 49 cerebral perfusion 49 orexin 49 brainwave patterns 49 serum triglyceride 49 Supplementation 49 GABA neurotransmitter 49 caloric restriction 49 sedentary behaviors 49 neuritic 49 nonalcoholic fatty liver 49 Genetic variants 49 urinary calcium 49 tertiles 49 UPDRS 49 magnesium supplements 49 vasodilatation 49 dyskinesia 49 premenopausal women 49 bone microarchitecture 49 neuroanatomical 49 premotor 49 clusterin 49 albumin excretion rate 49 FeNO 49 postprandial 49 vagal tone 49 POAG 49 diabetes mellitus 49 infarct size 49 androgen deficiency 49 serum ferritin 49 psychostimulants 49 tarenflurbil 49 bradykinesia 49 Alzheimer Disease AD 49 chromium picolinate supplementation 49 oxidative stress markers 49 CVD mortality 49 neurological impairment 49 dopamine receptors 49 premenopausal 49 coadministration 49 CYP#C# genotype 49 D2 receptors 49 euthyroid 49 behavioral interventions 49 A1 allele 49 GBA mutations 49 antioxidant nutrients 49 virologic response 49 carb dieters 49 improving insulin sensitivity 49 clinically meaningful improvement 49 endometrial cancer 49 nonfasting 49 gastric motility 49 comorbid disorders 49 PPAR γ 49 DNA methylation patterns 49 axonal damage 49 dobutamine 49 cardiac conduction 49 DASH diet 49 transthyretin 49 Gazzaley 49 ADHD 49 cardiorespiratory endurance 49 unsupplemented 49 corticosterone 49 noncognitive 49 postoperative mortality 49 inflammatory polyarthritis 49 cerebral glucose metabolism 49 left ventricular LV 49 carbohydrate absorption 49 blood Phe 49 serum urate levels 49 serum triglycerides 49 baroreceptor 49 hyperactivity inattention 49 IBMT 49 decreased libido 49 adult neurogenesis 49 CONCERTA ® 49 neurotoxicity 49 platelet clumping 49 alpha lipoic acid 49 thyroid stimulating hormone 49 Subgroup analyzes 49 spatial cognition 49 anticholinergic medications 49 postmenopausal hormone therapy 49 ischemic stroke 49 ski lls 49 submaximal exercise 49 drinking beetroot juice 49 QOL 49 analgesic effects 49 theanine 49 macular pigment 49 ob ob mice 49 thyrotropin 49 ventricular mass 49 endogenous opioids 49 lipid lowering medications 49 exploratory endpoints 49 mitochondrial fusion 49 maintaining cardiorespiratory fitness 49 hepatic function 49 preserved systolic 49 tic disorders 49 cotinine levels 49 Aerobic exercise 49 dysglycemia 49 mdx mice

Back to home page